Dalteparin Multi-Dose Vials and Sunitinib
Determining the interaction of Dalteparin Multi-Dose Vials and Sunitinib and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using SUNItinib together with dalteparin may increase the risk of bleeding. You should seek immediate medical attention if you experience any unusual bleeding or bruising, or have other signs and symptoms of bleeding such as dizziness; lightheadedness; red or black, tarry stools; coughing up or vomiting fresh or dried blood that looks like coffee grounds; severe headache; and weakness. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: The concomitant use of anticoagulants may theoretically increase the risk of sunitinib-induced bleeding. Severe and life-threatening tumor hemorrhage, hemoptysis, and pulmonary hemorrhage, and nonserious epistaxis have occurred during treatment with sunitinib.
MANAGEMENT: Monitoring for clinical and laboratory signs of bleeding is recommended during concomitant therapy, including INR/PT and complete blood counts. Patients should be advised to promptly report any potential signs of bleeding to their doctor, including nosebleeds, pain, swelling, or headache.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports. Available from: URL: http://www.ema.europa.eu/ema/index.jsp?curl=pages/includes/medicines/medicines_landingpage.jsp&mid."
Generic Name: dalteparin
Brand name: Fragmin
Synonyms: Dalteparin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dalteparin Multi-Dose Vials-Sunitinib Malate
- Dalteparin Multi-Dose Vials-Sunkist Vitamin C
- Dalteparin Multi-Dose Vials-Sunmark 12 Hour Allergy Relief
- Dalteparin Multi-Dose Vials-Sunmark Acid Reducer
- Dalteparin Multi-Dose Vials-Sunmark Acid Reducer Maximum Strength
- Dalteparin Multi-Dose Vials-Sunmark Acid Reducer Ranitidine
- Sunitinib-Dalteparin Sodium
- Sunitinib-Dalteparin Subcutaneous
- Sunitinib-Dalvance
- Sunitinib-Danaparoid
- Sunitinib-Danaparoid Subcutaneous
- Sunitinib-Danazol